Global Age-Related Macular Degeneration (AMD) Market 2014-2018

Global Age-Related Macular Degeneration (AMD) Market 2014-2018

Category : Healthcare
Published On : June  2014
Pages : 83

------------ Or -------------

About AMD
AMD is defined as the deterioration of the eye's macula. The macula is a small area in the retina that is responsible for central vision. The exact etiology of AMD is unknown. There are two types of macular degeneration: wet and dry. Wet AMD occurs when tiny abnormal blood vessels begin growing behind the retina toward the macula. Dry AMD occurs when small, yellowish deposits called drusen begin accumulating beneath the macula. While a number of treatments are available for wet AMD, there is no treatment available at the moment for dry AMD.
TechNavio's analysts forecast the Global AMD market will grow at a CAGR of 6.62 percent over the period 2013-2018.
Covered in this Report
The Global AMD market can be divided into two segments: Dry AMD and Wet AMD. This report covers the present scenario and the growth prospects of the Global AMD market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of AMD.
TechNavio's report, the Global AMD Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global AMD market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
Key Vendors
• Bayer AG 
• F. Hoffmann-La Roche Ltd.
• Novartis AG 
• Regeneron Pharmaceuticals Inc.
Other Prominent Vendors
• Acucela Inc.
• Advanced Cell Technology Inc.
• Alexion Pharmaceuticals Inc.
• Alimera Sciences Inc.
• Allergen Inc.
• Allergo Opthalmics LLC
• Avalanche Biotechnologies Inc.
• Gilead Sciences Inc.
• GlaxoSmithKline plc
• Icon Bioscience Inc.
• Intellect Neurosciences Inc.
• Lpath Inc.
• Neurotech Pharmaceuticals Inc.
• Opthotech Corp.
• OSI Pharmaceuticals Inc.
• Oxigene Inc.
• PanOptica Inc.
• Pfizer Inc.
• Santen Pharmaceutical Co. Ltd.
• StemCells Inc.
• Synthetic Biologics Inc.
• Thrombogenics NV
• Valeant Pharmaceuticals International Inc.
Key Market Driver
• Increase in Aging Population.
• For a full, detailed list, view our report.
Key Market Challenge
• Increase in Off Label Use.
• For a full, detailed list, view our report.
Key Market Trend
• Increase in Awareness of AMD.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

03.2.1 Product Profiles

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Product Portfolio of Current AMD Therapies

08. Clinical Pipeline Portfolio

09. Rate of Incidence and Prevalence

09.1.1 US

09.1.2 UK

09.1.3 Australia

09.1.4 Japan

09.1.5 China

09.1.6 India

10. Market Segmentation by Types

11. Geographical Segmentation

11.1 AMD Market in the Americas

11.1.1 Market Size and Forecast

11.2 AMD Market in the EMEA Region

11.2.1 Market Size and Forecast

11.3 AMD Market in the APAC Region

11.3.1 Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Market Analysis 2013

19.3 Other Prominent Vendors

19.4 Future Vendors Expected To Tap AMD Market

20. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global AMD Market 2013-2018 (US$ billion)

Exhibit 3: Global AMD Market Segmentation by Types

Exhibit 4: Global AMD Market by Geographical Segmentation 2013

Exhibit 5: AMD Market in the Americas 2013-2018 (US$ billion)

Exhibit 6: AMD Market in the EMEA Region 2013-2018 (US$ billion)

Exhibit 7: Global AMD Market by Major Product Share 2013


Enquiry Before Buy